 | • レポートコード：TPM-2JN104 • 出版社/出版日：Transparency Market Research / 2019年11月14日 • レポート形態：英文、PDF、232ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートはバイオイメージング試薬の世界市場について調査・分析し、序論、仮定・研究手法、エグゼクティブサマリー、市場状況、市場動向、クラス別分析、モダリティ別分析、用途別分析、エンドユーザー別分析、地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業概要などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究手法 ・エグゼクティブサマリー ・市場状況 ・市場動向 ・バイオイメージング試薬の世界市場：クラス別 ・バイオイメージング試薬の世界市場：モダリティ別 ・バイオイメージング試薬の世界市場：用途別 ・バイオイメージング試薬の世界市場：エンドユーザー別 ・バイオイメージング試薬の世界市場：地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ） ・バイオイメージング試薬の北米市場分析・予測 ・バイオイメージング試薬の欧州市場分析・予測 ・バイオイメージング試薬のアジア太平洋市場分析・予測 ・バイオイメージング試薬の中南米市場分析・予測 ・バイオイメージング試薬の中東・アフリカ市場分析・予測 ・競争状況 |
The use of nuclear medicine for research and disease treatment dates back to the first half of the 20th century, when they began to be used as tracer elements. Subsequent developments in nuclear medicine and molecular imaging have led to a variety of radiopharmaceutical substances being used for the diagnosis of different diseases. Nuclear imaging modalities such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT), which use these radiopharmaceuticals, are now being offered as a routine option in the diagnosis and treatment of diseases. With benefits such as better quality of images and precision in the detection of illnesses made possible, particularly in the early detection and diagnosis of cancers, nuclear imaging as a modality within the biological imaging reagents market has been gaining traction in recent years. This modality in the global biological imaging reagents market was valued at ~US$ 2.3 Bn in 2018 and is expected to expand the most among all, at a CAGR of ~9% during the forecast years.
The obvious advantages of multimodal imaging, or multiplexed imaging, over single modality imaging, such as better visualization and more precise images, have contributed significantly to their popularity. The introduction and incorporation of newer technologies and tools, particularly that use multiple imaging techniques, have gained purchase in the larger imaging landscape. For instance, the increased use of PET-SPECT hybrid and PET-MRI imaging systems globally, due to their many benefits, has contributed significantly to the expansion of the biological imaging reagents market.
Manufacturers in the global biological imaging reagents market, focusing on these multimodal techniques, are likely to witness increased potential in the field of research and drug discovery.
The larger imaging landscape has not been immune to the pervasive influence of technology, which has not just caused the industry to progress by leaps and bounds with the development of multimodal imaging techniques, but has also resulted in better prospects for standardized imaging. For instance, the incorporation of AI into molecular imaging is becoming increasingly popular, as the potential for AI to improve diagnostic accuracy is vast, and is only beginning to be explored. With these advancements being incorporated into existing imaging technologies, it has had a significant positive impact on the growth of the biological imaging reagents market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Biological Imaging Reagents Market
4. Market Overview
4.1. Introduction
4.1.1. Class Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Regulatory Scenario by Region/globally
5.2. Technological Advancements
5.3. Disease Prevalence & Incidence Rate globally with key countries
6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class, 2017–2027
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Class, 2017–2027
6.3.1. Contrast Reagents
6.3.2. Optical Reagents
6.3.3. Nuclear Reagents
6.4. Market Attractiveness, by Class
7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality, 2017–2027
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Modality, 2017–2027
7.3.1. MRI
7.3.2. Ultrasound
7.3.3. X-ray & CT
7.3.4. Nuclear
7.3.4.1. PET
7.3.4.2. SPECT
7.3.5. Optical Imaging
7.3.6. Others
7.4. Market Attractiveness, by Modality
8. Global Biological Imaging Reagents Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2027
8.3.1. In Vitro
8.3.1.1. Proteomics
8.3.1.2. Genomics
8.3.1.3. Cell Biology
8.3.2. In Vivo
8.4. Market Attractiveness, by Application
9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user, 2017–2027
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2027
9.3.1. Diagnostic Laboratories
9.3.2. Imaging Centers
9.3.3. Life Sciences Companies
9.3.4. Academic & Research Institutes
9.3.5. Others
9.4. Market Attractiveness, by End-user
10. Global Biological Imaging Reagents Market Analysis and Forecasts, by Region, 2017–2027
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Country/Region
11. North America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
11.1.Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Class, 2017–2027
11.2.1. Contrast Reagents
11.2.2. Optical Reagents
11.2.3. Nuclear Reagents
11.3. Market Value Forecast, by Modality, 2017–2027
11.3.1. MRI
11.3.2. Ultrasound
11.3.3. X-ray & CT
11.3.4. Nuclear
11.3.4.1. PET
11.3.4.2. SPECT
11.3.5. Optical Imaging
11.3.6. Others
11.4. Market Value Forecast, by Application, 2017–2027
11.4.1. In Vitro
11.4.1.1. Proteomics
11.4.1.2. Genomics
11.4.1.3. Cell Biology
11.4.2. In Vivo
11.5. Market Value Forecast, by End-user, 2017–2027
11.5.1. Diagnostic Laboratories
11.5.2. Imaging Centers
11.5.3. Life Sciences Companies
11.5.4. Academic & Research Institutes
11.5.5. Others
11.6. Market Value Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Class
11.7.2. By Modality
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Class, 2017–2027
12.2.1. Contrast Reagents
12.2.2. Optical Reagents
12.2.3. Nuclear Reagents
12.3. Market Value Forecast, by Modality, 2017–2027
12.3.1. MRI
12.3.2. Ultrasound
12.3.3. X-ray & CT
12.3.4. Nuclear
12.3.4.1. PET
12.3.4.2. SPECT
12.3.5. Optical Imaging
12.3.6. Others
12.4. Market Value Forecast, by Application, 2017–2027
12.4.1. In Vitro
12.4.1.1. Proteomics
12.4.1.2. Genomics
12.4.1.3. Cell Biology
12.4.2. In Vivo
12.5. Market Value Forecast, by End-user, 2017–2027
12.5.1. Diagnostic Laboratories
12.5.2. Imaging Centers
12.5.3. Life Sciences Companies
12.5.4. Academic & Research Institutes
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Class
12.7.2. By Modality
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Class, 2017–2027
13.2.1. Contrast Reagents
13.2.2. Optical Reagents
13.2.3. Nuclear Reagents
13.3. Market Value Forecast, by Modality, 2017–2027
13.3.1. MRI
13.3.2. Ultrasound
13.3.3. X-ray & CT
13.3.4. Nuclear
13.3.4.1. PET
13.3.4.2. SPECT
13.3.5. Optical Imaging
13.3.6. Others
13.4. Market Value Forecast, by Application, 2017–2027
13.4.1. In Vitro
13.4.1.1. Proteomics
13.4.1.2. Genomics
13.4.1.3. Cell Biology
13.4.2. In Vivo
13.5. Market Value Forecast, by End-user, 2017–2027
13.5.1. Diagnostic Laboratories
13.5.2. Imaging Centers
13.5.3. Life Sciences Companies
13.5.4. Academic & Research Institutes
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Class
13.7.2. By Modality
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Class, 2017–2027
14.2.1. Contrast Reagents
14.2.2. Optical Reagents
14.2.3. Nuclear Reagents
14.3. Market Value Forecast, by Modality, 2017–2027
14.3.1. MRI
14.3.2. Ultrasound
14.3.3. X-ray & CT
14.3.4. Nuclear
14.3.4.1. PET
14.3.4.2. SPECT
14.3.5. Optical Imaging
14.3.6. Others
14.4. Market Value Forecast, by Application, 2017–2027
14.4.1. In Vitro
14.4.1.1. Proteomics
14.4.1.2. Genomics
14.4.1.3. Cell Biology
14.4.2. In Vivo
14.5. Market Value Forecast, by End-user, 2017–2027
14.5.1. Diagnostic Laboratories
14.5.2. Imaging Centers
14.5.3. Life Sciences Companies
14.5.4. Academic & Research Institutes
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Class
14.7.2. By Modality
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Class, 2017–2027
15.2.1. Contrast Reagents
15.2.2. Optical Reagents
15.2.3. Nuclear Reagents
15.3. Market Value Forecast, by Modality, 2017–2027
15.3.1. MRI
15.3.2. Ultrasound
15.3.3. X-ray & CT
15.3.4. Nuclear
15.3.4.1. PET
15.3.4.2. SPECT
15.3.5. Optical Imaging
15.3.6. Others
15.4. Market Value Forecast, by Application, 2017–2027
15.4.1. In Vitro
15.4.1.1. Proteomics
15.4.1.2. Genomics
15.4.1.3. Cell Biology
15.4.2. In Vivo
15.5. Market Value Forecast, by End-user, 2017–2027
15.5.1. Diagnostic Laboratories
15.5.2. Imaging Centers
15.5.3. Life Sciences Companies
15.5.4. Academic & Research Institutes
15.5.5. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Class
15.7.2. By Modality
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Position/Ranking Analysis, by Company (2018)
16.3. Company Profiles
16.3.1. Bayer AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Thermo Fisher Scientific, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. PerkinElmer, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Guerbet
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Lantheus Holdings, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Bracco S.p.A.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. GE Healthcare
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Becton, Dickinson and Company (BD)
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. Siemens Healthineers
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis
16.3.10. Luminex Corporation
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Company Financials
16.3.10.3. Growth Strategies
16.3.10.4. SWOT Analysis
List of TablesTable 01: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027
Table 02: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 03: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027
Table 04: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 05: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027
Table 06: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 07: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 08: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027
Table 10: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 11: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027
Table 12: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 13: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027
Table 14: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 15: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027
Table 17: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 18: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027
Table 19: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 20: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027
Table 21: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 22: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027
Table 24: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 25: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027
Table 26: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 27: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027
Table 28: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 29: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 30: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027
Table 31: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 32: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027
Table 33: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 34: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027
Table 35: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 36: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 37: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027
Table 38: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 39: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027
Table 40: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 41: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027
Table 42: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027